Understanding Your MS Brain MRI: What Lesions, Black Holes, and Enhancing Spots Mean

You just got your MRI results back, and the report is filled with terms you don't recognize. "Periventricular white matter lesions." "No enhancing lesions." "Stable disease burden." You're not sure whether to be relieved or terrified. If this sounds familiar, you're not alone. MRI reports are written for radiologists and neurologists, not for patients, and I've seen how much unnecessary anxiety they can cause when read without context.

This guide will walk you through exactly what your MS brain MRI results mean, what each type of lesion tells us about your disease, and when findings are genuinely concerning versus when you can take a breath and feel reassured. Understanding your MRI is one of the most empowering things you can do as someone living with multiple sclerosis.

Why MRI Is Essential for MS

MRI is the single most important tool we have for diagnosing and monitoring multiple sclerosis. Unlike many other neurological conditions, MS often causes changes in the brain and spinal cord that are visible on MRI long before they cause noticeable symptoms.

For diagnosis, MRI helps us apply the 2024 McDonald criteria, which require evidence that demyelination has occurred in multiple areas of the central nervous system at different points in time. MRI can often demonstrate both of these requirements in a single scan.

For monitoring, regular MRIs allow us to track whether your disease is active beneath the surface. This is critical because MS can form new lesions silently, without causing symptoms you'd notice. In my practice, I've had patients whose scans showed several new lesions despite feeling perfectly fine. Without the MRI, we would have missed the opportunity to optimize their treatment before irreversible damage accumulated.

Types of MS Lesions Explained

Not all lesions on an MS brain MRI are the same. Each type tells a different story about what's happening in your brain, and understanding the differences is key to making sense of your report.

T2/FLAIR Lesions: The White Spots

T2-weighted and FLAIR (Fluid-Attenuated Inversion Recovery) sequences are the bread and butter of MS imaging. On these sequences, white matter lesions appear as bright white spots against the darker brain tissue.

These lesions represent areas where the myelin coating around nerve fibers has been damaged by neuroinflammation. The total number and volume of T2 lesions on your MRI is often referred to as your disease burden or lesion load. Think of T2 lesions as the cumulative footprint of everything your MS has done over time. They include both old, healed lesions and newer ones.

One important thing to understand: a T2 lesion doesn't necessarily mean permanent damage. Some T2 lesions reflect areas that have partially remyelinated and recovered. Others represent more significant injury. The MRI alone can't always distinguish between the two.

Gadolinium-Enhancing Lesions: Active Inflammation

When you receive gadolinium contrast dye through an IV during your MRI, it highlights areas where the blood-brain barrier has broken down. In MS, this breakdown occurs when the immune system is actively attacking myelin. These enhancing lesions light up brightly on the post-contrast images.

Enhancing lesions are the most direct evidence of recent disease activity. They are typically less than four to six weeks old, which means they tell us that your MS has been active very recently. This is one of the most important findings your neurologist looks for when assessing whether your current treatment is working.

I always explain it to patients this way: T2 lesions are the scars from every fire that's ever burned. Enhancing lesions are the fires that are burning right now. Finding no enhancing lesions on your MRI is generally a very good sign.

T1 Black Holes: Chronic Damage

On T1-weighted sequences, some MS lesions appear as dark spots, often called black holes. These represent areas of more severe, chronic tissue destruction where significant axonal loss has occurred.

Not all dark spots on T1 are permanent. Some T1 hypointense lesions seen during an active relapse will resolve as inflammation settles. But lesions that persist as black holes on follow-up scans months later indicate irreversible damage. A higher number of persistent T1 black holes is generally associated with greater disability over time.

Black holes are one reason I emphasize early, effective treatment to my patients. The goal of disease-modifying therapy is not just to prevent relapses you can feel but to prevent the kind of silent tissue destruction that leads to black holes and long-term disability.

Spinal Cord Lesions

MS doesn't only affect the brain. Spinal cord lesions are found in the majority of people with MS and can cause symptoms like weakness, numbness, walking difficulty, and bladder problems — a presentation sometimes called transverse myelitis when it occurs as an acute inflammatory attack. Spinal cord MRI is an important part of the diagnostic workup and may be repeated when new spinal symptoms develop.

Spinal cord lesions in MS are typically short (spanning fewer than two vertebral segments), partial-cross-section, and located in the cervical cord. This pattern helps distinguish MS from conditions like neuromyelitis optica (NMO) and MOGAD, which tend to cause longer, more centrally located spinal cord lesions.

Where MS Lesions Typically Appear

The location of lesions on MRI is just as important as their number. MS has a characteristic pattern of lesion distribution that helps neurologists distinguish it from other causes of white matter lesions. The McDonald criteria specifically require lesions in certain locations:

• Periventricular -- adjacent to the fluid-filled ventricles in the center of the brain. These are the most common location for MS lesions and are highly characteristic of the disease.
• Juxtacortical/cortical -- at or near the surface of the brain, at the junction between gray and white matter.
• Infratentorial -- in the brainstem and cerebellum, the structures at the base of the brain that control balance, coordination, and eye movements.
• Spinal cord -- as described above, typically short lesions in the cervical or thoracic cord.

Having lesions in at least two of these characteristic locations helps establish dissemination in space, one of the core requirements for an MS diagnosis. This is why your radiologist's report will often specifically note the location of each lesion.

How to Read Your MRI Report

MRI reports can feel like they're written in a foreign language. Here are the key terms you're likely to encounter and what they mean in plain language:

• "Stable" -- Your lesions haven't changed since the last scan. This is generally good news and suggests your disease has been quiet.
• "New lesion" -- A lesion that wasn't on your previous scan. This indicates disease activity has occurred since your last MRI, even if you didn't notice symptoms.
• "Enhancing" or "enhancement" -- A lesion that lights up with gadolinium contrast, indicating active inflammation within the past four to six weeks.
• "No enhancing lesions" -- No evidence of active inflammation. This is what we hope to see on a monitoring scan.
• "Atrophy" or "volume loss" -- The brain has lost some volume compared to prior scans. Some atrophy occurs with normal aging, but accelerated atrophy can be a sign of ongoing MS-related neurodegeneration.
• "Disease burden" or "lesion load" -- The total number and volume of lesions. Radiologists may describe this as mild, moderate, or severe.
• "Nonspecific white matter changes" -- A vague term sometimes used when the radiologist sees white spots but isn't certain they represent MS. This can be frustrating, but it highlights why interpretation by an MS specialist is so important.

Comparison: Types of MRI Lesions in MS

MRI Monitoring Schedule

Regular MRI monitoring is a cornerstone of MS management. How often you need scans depends on several factors:

• Newly diagnosed or starting new treatment: MRI every three to six months to establish a new baseline and assess early treatment response
• Stable on treatment with no recent activity: MRI every six to twelve months
• Breakthrough disease activity: More frequent scanning as determined by your neurologist
• Long-term stable disease on highly effective therapy: Some specialists may extend to annual or longer intervals, though this is individualized

Your neurologist will typically order a brain MRI without contrast for monitoring. Sometimes contrast may be needed if you are having active symptoms and it helps detect enhancing lesions. Spinal cord MRI may be added if you develop new spinal symptoms or if it's needed for diagnostic clarification.

I recommend that my patients always request a copy of each MRI on disc or through their imaging center's portal. Having access to your prior scans allows any neurologist to make accurate comparisons, which is especially important if you ever change providers or seek a second opinion.

What New Activity on MRI Means for Your Treatment

Finding new lesions on a monitoring MRI is one of the most important signals in MS management. Here's how your neurologist will typically think about it:

New T2 lesions without enhancement: These developed at some point since your last scan but are no longer actively inflamed. One or two small new T2 lesions may prompt closer monitoring. Multiple new T2 lesions are a stronger signal that your current therapy may not be controlling your disease adequately.

New enhancing lesions: These represent active inflammation right now. Even a single enhancing lesion on treatment is a red flag that warrants a conversation about whether your current disease-modifying therapy is effective enough. Your neurologist may recommend switching to a more potent medication.

Increasing atrophy: Accelerated brain volume loss beyond what's expected for age can be a sign of ongoing inflammation and damage. This is an area of growing importance in MS monitoring and treatment decisions. Complementary tools like the neurofilament light chain blood test can provide additional insight into nerve damage between MRI scans.

When we see new activity, the question isn't just "what happened?" but "what do we do about it?" In many cases, new MRI activity while on treatment means it's time to escalate to a higher-efficacy therapy. The goal is what we call NEDA -- No Evidence of Disease Activity -- meaning no relapses, no new MRI lesions, and no disability progression.

When to Worry vs When to Feel Reassured

Reassuring Findings

• "Stable MRI, no new lesions, no enhancing lesions" -- This is the best result you can get on a monitoring scan. Your treatment is doing its job.
• A small number of T2 lesions that haven't changed -- Existing lesions don't disappear, so seeing the same ones is expected and normal.
• No enhancing lesions -- No evidence of active inflammation.

Findings Worth Discussing with Your Neurologist

• One or two new small T2 lesions -- Warrants closer monitoring and a discussion about treatment adequacy.
• Mild atrophy -- Some is normal with aging, but your neurologist should track the trend.
• Nonspecific findings -- If your radiologist uses vague language, ask your neurologist for clarification.

Findings That Require Prompt Attention

• Multiple new T2 lesions -- Suggests your disease has been significantly active.
• Any enhancing lesions on treatment -- Indicates active inflammation breaking through your medication.
• New large or tumefactive lesions -- Unusually large lesions need additional evaluation.
• Significant new atrophy -- May indicate ongoing neurodegeneration requiring treatment adjustment.
• Atypical lesion patterns -- Patterns that don't look like typical MS may prompt your neurologist to reconsider the diagnosis or evaluate for NMO or MOGAD.

When to See Your MS Specialist About MRI Results

You should contact your MS specialist whenever you receive MRI results, even if they appear stable. Your neurologist interprets the images in context with your full clinical picture, not just the radiology report. Beyond routine review, reach out promptly if:

• Your report mentions new or enhancing lesions
• You're experiencing new symptoms that could represent a relapse
• Your report uses language you don't understand and it's causing you anxiety
• You've noticed cognitive changes like brain fog and want to correlate them with your MRI findings
• You want a second opinion on your MRI interpretation

At Achilles Neurology Clinic in Beverly Hills, we provide comprehensive MS evaluations including detailed MRI review, treatment planning, and ongoing monitoring. Dr. Ntranos personally reviews every patient's MRI images -- not just the radiology report -- to ensure nothing is missed. We also offer telehealth consultations for patients across California who need expert MRI interpretation and MS management.

Frequently Asked Questions

What do the different types of lesions on my MS MRI mean?

On an MS brain MRI, T2/FLAIR lesions (bright spots) represent areas where myelin has been damaged and show your total disease burden. Gadolinium-enhancing lesions indicate active inflammation within the past four to six weeks. T1 black holes represent chronic, permanent damage. Together, these findings help your neurologist assess disease activity, track changes over time, and determine whether your treatment is working effectively.

What are enhancing lesions on an MS MRI?

Enhancing lesions light up on MRI after gadolinium contrast dye is injected. They indicate active inflammation where the blood-brain barrier has broken down, meaning the immune system is currently attacking myelin in that area. Enhancing lesions are typically less than four to six weeks old and are a sign that your MS has been recently active, which may prompt your neurologist to consider a treatment change.

What are black holes on an MS brain MRI?

Black holes are areas that appear dark on T1-weighted MRI sequences. They represent chronic, permanent damage where significant tissue destruction and axonal loss have occurred. Unlike T2 lesions which can reflect varying degrees of inflammation and repair, persistent black holes indicate irreversible injury. The presence of many black holes is generally associated with greater disability.

How often should I get an MRI for MS monitoring?

Most MS specialists recommend brain MRI every six to twelve months, depending on your disease activity and treatment status. More frequent monitoring may be needed when you are newly diagnosed, recently started a new medication, or have had recent disease activity. Once your MS is well-controlled on a stable therapy, your neurologist may extend the interval. Spinal cord MRI is typically done less frequently unless you have spinal symptoms.

Can MS lesions go away?

Some MS lesions can shrink or become less visible on MRI over time as inflammation resolves and partial remyelination occurs. Enhancing lesions typically stop enhancing within a few weeks as the active inflammation settles. However, most T2 lesions leave a permanent footprint on MRI even after recovery. T1 black holes represent permanent damage and do not resolve.

Should I worry about new lesions on my MRI?

New lesions indicate that your MS has been active, but they do not necessarily mean your prognosis is poor. A single new small lesion without symptoms may simply prompt closer monitoring, while multiple new enhancing lesions could signal that your current treatment is not adequately controlling your disease. The important thing is to discuss any new findings with your MS specialist, who can put them in context with your overall clinical picture and adjust your treatment plan if needed.

About the Author

Dr. Achillefs Ntranos MD

Board-Certified Neurologist
Achilles Neurology Clinic

Dr. Achillefs Ntranos MD is a board-certified neurologist and MS specialist known for his thorough evaluations and compassionate approach. Originally from Greece, he trained at Johns Hopkins University and Mount Sinai Hospital before founding Achilles Neurology Clinic in Beverly Hills to deliver comprehensive, patient-centered neurological care. He specializes in MS, autoimmune neurology, neuropathy, headaches, and other neurological disorders, blending research-driven insights with personalized treatment plans.

Learn More About Dr. Ntranos(310) 774-7025